Pfizer Pain Cutback Shutters UK R&D Site
This article was originally published in Scrip
Pfizer, Inc. is cutting back its investment in early R&D into pain, and as a result will close its Neusentis research facility in Cambridge, UK. The move will result in the loss of up to 120 jobs.
Register for our free email digests: